Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bayer
Pharma
FDA approves use of Bayer's Nubeqa in all patients with mCSPC
Bayer has scored an important FDA label expansion for Nubeqa, which now can be used by all patients with metastatic castration-sensitive prostate cancer.
Kevin Dunleavy
Jun 4, 2025 11:38am
Bayer weathers LOE for Xarelto with success of Kerendia, Nubeqa
May 13, 2025 11:25am
Bayer wins appeal in case of ‘warming’ market for Eylea launch
Apr 29, 2025 9:00am
Top 20 pharma companies by 2024 revenue
Apr 21, 2025 3:00am
Novo, Merck, Hengrui-Elevar—Fierce Pharma Asia
Mar 28, 2025 9:28am
FBI, police probe potential arson at Bayer exec's home: reports
Mar 14, 2025 10:18am
